The PPMA USA 2017 prospectus details everything you'll need to know to be a part of the event this year.
The World Pharma Pricing & Market Access Congress is the most comprehensive and holistic event for access, pricing, and reimbursement leaders in pharma.
Achieving patient access to innovative medicines continues to be a significant challenge for the US pharma and biotech industries. Add newfound uncertainty around federal policy on the ACA into a healthcare market that is already growing in complexity and you have an industry facing seemingly impossible obstacles on its quest to achieve reimbursement and secure win-win pricing.
That’s why Pharma Pricing & Market Access USA, is more important than ever as a 2-dayforum for pharma, payers, patient groups and providers to discuss, debate and develop a way forward for US healthcare. Representatives of America’s most important health plans, ACOs, government agencies and patient groups will collaborate and co-create a strategy for success with pharma’s leading innovators.
What’s more, by co-locating with
Evidence USA 2017
, this event offers attendees a unique perspective on maximizing market access value through real world data.
Join 300 of your peers in Philadelphia this October.